Reactivity of Fibrinogen Crosslinking Sites in the Absence of Thrombin

Summary

The reactivity of fibrinogen crosslinking sites with thrombin-free, preactivated factor XIII (F. Xllla) was investigated under different conditions such as increased ionic strength, presence of urea, protamine sulfate (PS) or of varying concentrations of monodansylcadaverine (MDC). Crosslinking and incorporation of MDC into fibrinogen or fibrin γ- and α-chains were evaluated by SDS-Polyacrylamide gel electrophoresis.

According to our results, rates of crosslinking of, and of MDC incorporation into, both γ-and α-chains of fibrinogen were low under physiological conditions; they were not significantly influenced by the presence of either 1.0 M NaCl or 1.0 M urea. In contrast, 0.01 % PS precipitated fibrinogen, and, simultaneously, significantly increased the rates of crosslinking and of MDC incorporation into both γ- and α-chains. MDC, at concentrations above approximately 6 mM, also precipitated fibrinogen, and, up to a concentration of about 9 mM, markedly enhanced the reactivity of acceptor crosslinking sites.

Our results suggest that solubility of fibrinogen and the conformational arrangement of its subunit chains are closely interdependent; the reactivity of crosslinking sites with F. Xllla seems to be a function of this conformational state.

• References

• 1 Blombäck B. 1958; Studies on the action of thrombotic enzymes on bovine fibrinogen as measured by N-terminal analysis. Arkiv for Kemi 12: 321.
• 2 Cuatregasas P, Wilcheck M, Anfinsen C. B. 1968; Selective enzyme purification by affinity chromatography. Proceedings of the National Academy of Sciences U.S.A 61: 636.
• 3 Doolittle R. F. 1973; Structural aspects of the fibrinogen to fibrin conversion. Advances in Protein Chemistry 27: 1.
• 4 Hudry-Clergeon G. 1973 Contribution à l’étude du fibrinogéne et de la fibrinoformation. These, Université Scientifique et Médicale de Grenoble.
• 5 Hudry-Clergeon G, Marguerie G, Pouit L, Suscillon M. 1975; Models proposed for the fibrinogen molecule and for the polymerization process. Thrombosis Research 6: 533.
• 6 Kazama M, Langdell R. D. 1969; Purification of fibrin stabilizing factor (FSF). Federation Proceedings 28: 746.
• 7 Loewy A. G, Dunathan K, Kriel R, Wolfinger Jr. H. L. 1961; Fibrinase I. Purification of substrate and enzyme. Journal of Biological Chemistry 236: 2625.
• 8 Lorand L, Rule N. G, Ong H. H, Furlanetto R, Jacobsen A, Downey J, Öner N, Bruner-Lorand J. 1968; Amine specifity in transpeptidation. Inhibition of fibrin crosslinking. Biochemistry, 7: 1214.
• 9 Lorand L, Urayama T, de Kiwiet J. W. C, Nossel H. L. 1969; Diagnostic and genetic studies on fibrin stabilizing factor with a new assay based on amine incorporation. Journal of Clinical Investigation 48: 1054.
• 10 Mosesson M. W, Finlayson J. S. 1963; Subfractions of human fibrinogen. Preparation and analysis. Journal of Laboratory and Clinical Medicine 62: 663.
• 11 Mylon E, Winternitz M. C. Sütö-Nagy 1942; The determination of fibrinogen with protamine. Journal of Biological Chemistry 143: 21.
• 12 Pouit L, Marcille G, Suscillon M, Hollard D. 1972; Etude en microscopie électronique de différentes étapes de la fibrinoformation. Thrombosis et Diathesis Haemorrhagica 27: 559.
• 13 Shainoff J. R, Page I. H. 1960; Cofibrins and fibrin intermediates as indicators of thrombin activity in vivo. Circulation Research 8: 1013.
• 14 Shapiro A. L, Vinuela E, Maizel J. V. 1967; Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels. Biochemical and Biophysical Research Communications 28: 815.
• 15 Stewart G. J, Niewiarowski S. 1969; Nonenzymatic polymerization of fibrinogen by protamine sulfate. An electron microscope study. Biochimica et Biophysica Acta 194: 462.
• 16 Stryer L, Cohen C, Langridge R. 1963; Axial period of fibrinogen and fibrin. Nature 7 (97) 793.